23.76 -0.50 (-2.06%)

New 52W Low today

1.5M XNAS Volume

XNAS 25 Mar, 2025 5:30 PM (EDT)

Apellis Pharmaceuticals Inc - APLS - stock price prediction, stock price target, analyst ratings from 22 analysts

Apellis Pharmaceuticals Inc has a share price target of US$ 43, revenue growth forecast of 10.8%, and profit growth estimate of 35.1% for FY25, based on top 22 analyst calls.